Updated Safety and Efficacy Results of Abbv-383, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in a First-in-Human Phase 1 Study in Patients with Relapsed/Refractory Multiple MyelomaRavi Vij,Shaji Kunnathu Kumar, Anita D'Souza, John T Mckay,Peter M. Voorhees,Alfred Chung,Sascha Alexander Tuchman,Neha Korde,Katja Weisel,Raphael Teipel,Orlando Bueno, Zhongling Feng, Tanya S Rosenberg,Rajvineeth Kumar Pothacamury,Akshanth R Polepally,Shane Lee,Ziyi Jin,Jeremy A Ross, Aarif Ahsan,Chetasi TalatiBlood（2023）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
